Home » Topics » Regulatory

Regulatory
RSS

Dynepo receives E.U. approval for anemia of renal failure

March 28, 2002

Zindaclin launched in the U.K. as once-daily acne treatment

March 27, 2002

Roche's MabThera and Xeloda cleared for new indications in Europe

March 26, 2002

Remicade granted priority review as Crohn's disease monotherapy

March 25, 2002

Label change for Xenical cleared by CPMP

March 25, 2002

FDA approval for Avinza for once-daily treatment of chronic pain

March 22, 2002

Health Canada approves expanded label for ProstaScint

March 20, 2002

FDA approval for new formulation of Visicol

March 18, 2002

Risperdal approved for delaying schizophrenia relapse in U.S.

March 15, 2002

Extended-release Zerit has similar virological activity to immediate-release drug

March 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...